Get access

Cucurbit[7]uril Containers for Targeted Delivery of Oxaliplatin to Cancer Cells

Authors

  • Dr. Liping Cao,

    1. Department of Chemistry and Biochemistry, University of Maryland, College Park, MD 20742 (USA)
    Search for more papers by this author
    • These authors contributed equally to this work.

  • Gaya Hettiarachchi,

    1. Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742 (USA)
    Search for more papers by this author
    • These authors contributed equally to this work.

  • Prof. Dr. Volker Briken,

    Corresponding author
    1. Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742 (USA)
    • Volker Briken, Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742 (USA)

      Lyle Isaacs, Department of Chemistry and Biochemistry, University of Maryland, College Park, MD 20742 (USA)

    Search for more papers by this author
  • Prof. Dr. Lyle Isaacs

    Corresponding author
    1. Department of Chemistry and Biochemistry, University of Maryland, College Park, MD 20742 (USA)
    • Volker Briken, Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742 (USA)

      Lyle Isaacs, Department of Chemistry and Biochemistry, University of Maryland, College Park, MD 20742 (USA)

    Search for more papers by this author

  • L.I. thanks the National Science Foundation (CHE-1110911) and V.B. thanks the National Cancer Institute of the NIH (R01 CA168365) for financial support. G.H. thanks the University of Maryland for a Wylie Fellowship.

Abstract

original image

Zielgerichtet: Das Cucurbit[7]uril-Derivat 1, das einen kovalent gebundenen Biotinliganden trägt, ermöglicht den gezielten Transport von Oxaliplatin in Form des 1⋅Oxaliplatin-Komplexes zu Krebszellen. Das System führt zu einer höheren Cytotoxizität als Oxaliplatin alleine.

Ancillary